Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of BioXcel Therapeutics (NASDAQ:BTAI) through any online brokerage.
Other companies in BioXcel Therapeutics’s space includes: Aligos Therapeutics (NASDAQ:ALGS), FibroGen (NASDAQ:FGEN), Barinthus Biotherapeutics (NASDAQ:BRNS), MAIA Biotechnology (AMEX:MAIA) and Apimeds Pharmaceuticals (AMEX:APUS).
BioXcel Therapeutics has a consensus price target of $19.69.
The stock price for BioXcel Therapeutics (NASDAQ: BTAI) is $1.7099 last updated November 12, 2025 at 2:44 PM EST.
There are no upcoming dividends for BioXcel Therapeutics.
BioXcel Therapeutics’s Q3 earnings are confirmed for Wednesday, November 12, 2025.
There is no upcoming split for BioXcel Therapeutics.
BioXcel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.